Skip to main content

Inflammatory Bowel Disease and cannabis in North Carolina

The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Not on the qualifying list
✗ No
LEGAL
CBD oil with ≤0.9% THC,…
POSSESSION
$0/yr
STATE FEE
14–60 d
TIMELINE
Not on the qualifying list. The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

North Carolina statute and program

The North Carolina Epilepsy Alternative Treatment Act (CBD oil only) is the operating authority for North Carolina patient certification. The authoritative legal text is: N.C. Gen. Stat. § 90-94.1: Epilepsy Alternative Treatment Act.

What the evidence says about cannabis and Inflammatory Bowel Disease

. Both produce abdominal pain, diarrhea, fatigue, weight loss, and extraintestinal complications. The conditions differ in inflammation pattern: Crohn's can affect any part of the GI tract in patchy distribution, while ulcerative colitis is restricted to the colon in continuous distribution.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Inflammatory Bowel Disease page.

How to qualify in North Carolina

The North Carolina Epilepsy Alternative Treatment Act (CBD oil only) requires the following registration steps for a Inflammatory Bowel Disease patient (or any qualifying diagnosis):

  1. Get a neurologist’s written statement under the Epilepsy Alternative Treatment Act. A North Carolina-licensed neurologist must provide a written statement under N.C.G.S. §90-94.1 confirming that the patient has intractable epilepsy and may benefit from "hemp extract" (cannabis oil containing not more than 0.9% THC and at least 5% CBD by weight). The statute applies only to intractable epilepsy — North Carolina does not operate a general medical cannabis program.
  2. Register with the North Carolina Department of Health and Human Services. The patient or the patient’s legal guardian registers with the North Carolina Department of Health and Human Services using the neurologist’s written statement, a North Carolina driver license or state ID, and proof of residency. There is no separate online portal; registration is handled by mail or in person at NC DHHS.
  3. No state registration fee. North Carolina does not charge a patient registration fee under §90-94.1. There is also no dispensary infrastructure: the statute authorizes "registered caregivers" — typically a parent of a child with intractable epilepsy — to possess and administer hemp extract obtained out of state. The Cherokee Indian Hospital (on Eastern Band of Cherokee Indians sovereign land in Cherokee, NC) operates the only in-state medical cannabis dispensary, available to registered tribal members only.
  4. Obtain hemp extract from out of state or the EBCI dispensary. Registered patients may possess hemp extract obtained from out-of-state cannabis programs (most commonly Colorado, Virginia, or Washington). The Eastern Band of Cherokee Indians’ Qualla Enterprises tribal dispensary in Cherokee, NC operates a tribal medical cannabis program for enrolled members. North Carolina does not honor out-of-state medical cards for general use, but registered hemp-extract patients have an affirmative defense under §90-94.1 against possession charges.
State registration fee
$0
Physician visit (typical)
$200–$400
Certification to card
14–60 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full North Carolina registration steps, fees, and reciprocity rules, see the North Carolina cannabis-laws page.

ICD-10 code

A certifying physician documenting Inflammatory Bowel Disease for the North Carolina medical cannabis program will typically record ICD-10 K51.90 or SNOMED-CT 24526004 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does North Carolina list Inflammatory Bowel Disease as a qualifying condition for medical cannabis?

No. North Carolina's qualifying-condition list does not currently include Inflammatory Bowel Disease, and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Inflammatory Bowel Disease in North Carolina have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. North Carolina program rules change, so verify the current list with the regulator before drawing a final conclusion.

How do I get a North Carolina medical marijuana card for Inflammatory Bowel Disease?

Because North Carolina does not currently list Inflammatory Bowel Disease as a qualifying condition, a card for Inflammatory Bowel Disease alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in North Carolina who is registered with North Carolina Epilepsy Alternative Treatment Act (CBD oil only) and willing to evaluate Inflammatory Bowel Disease cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. North Carolina does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. Confirm the current process with the state regulator before applying, because the rules change.

What does the evidence say about cannabis for Inflammatory Bowel Disease?

For Inflammatory Bowel Disease, evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Inflammatory Bowel Disease lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Inflammatory Bowel Disease should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Inflammatory Bowel Disease and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Inflammatory Bowel Disease; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. N.C. Gen. Stat. § 90-94.1: Epilepsy Alternative Treatment Actaccessed May 15, 2026
  2. NORML: North Carolina Lawsaccessed May 15, 2026
  3. Wikipedia: Cannabis in North Carolinaaccessed May 15, 2026
  4. N.C. Gen. Stat. §90-95: Violations; penalties (controlled substances)accessed May 17, 2026
  5. Eastern Band of Cherokee Indians (EBCI) — Great Smoky Cannabis Co. (Qualla Boundary tribal dispensary)accessed May 17, 2026
  6. North Carolina Department of Agriculture: Industrial Hemp Programaccessed May 17, 2026
  7. North Carolina General Assembly bill trackeraccessed May 17, 2026
  8. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 15, 2026
  9. Crohn's & Colitis Foundationaccessed May 15, 2026